RISK OF MALIGNANCY AND SEVERE INFECTION IN A POPULATION OF RHEUMATOID ARTHRITIS PATIENTS TREATED WITH BIOLOGICS OR DMARDS

被引：0
作者：
Gilliaux, Q. [1 ]
Stoenoiu, M. [1 ]
de Bellefon, L. Meric [1 ]
Depresseux, G. [1 ]
Toukap, A. Nzeusseu [1 ]
Lauwerys, B. [1 ]
Houssiau, F. [1 ]
Durez, P. [1 ]
机构：
[1] Catholic Univ Louvain, Inst Rech Expt & Clin, Clin Univ St Luc, Rheumatol,Serv & Pole Rhumatol, Brussels, Belgium
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2015年 / 74卷
关键词：
D O I：
10.1136/annrheumdis-2015-eular.6217
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0163
引用
收藏
页码：711 / 712
页数：2
相关论文
共 50 条
  • [21] Prednisone and functional disability, not DMARDs or biologics, explain increased infection rates in rheumatoid arthritis (RA).
    Wolfe, F
    Flowers, N
    Anderson, J
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S403 - S403
  • [22] Quality of Life of Rheumatoid Arthritis Patients Treated with Biologics
    Trope, Sonia
    Thibaud, Gerard
    Alliot, Francoise
    Formont, Didier
    Krouri, Sadek
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [23] Risk of Venous Thromboembolism in Rheumatoid Arthritis Patients Treated with Biologic and Non-Biologic Dmards
    Maro, Judith
    Menzin, Talia
    Hornbuckle, Kenneth
    Giles, Jon T.
    Kavanaugh, Arthur
    Doerner, Thomas
    Martin, David
    Huang, Jane
    Salinas, Claudia A.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [24] Infection risk in patients with rheumatoid arthritis treated with etanercept or adalimumab
    Chiang, Yi-Chun
    Kuo, Li-Na
    Yen, Yu-Hsuan
    Tang, Chao-Hsiun
    Chen, Hsiang-Yin
    COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 2014, 116 (03) : 319 - 327
  • [25] RISK OF VENOUS THROMBOEMBOLISM IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH BIOLOGIC AND NON-BIOLOGIC DMARDS
    Maro, J. C.
    Menzin, T.
    Hornbuckle, K.
    Giles, J. T.
    Kavanaugh, A.
    Doerner, T.
    Martin, D.
    Huang, T.
    Salinas, C. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 932 - 932
  • [26] The Risk of Malignancy in Korean Patients with Rheumatoid Arthritis
    Lee, Hwajeong
    YONSEI MEDICAL JOURNAL, 2019, 60 (02) : 223 - 229
  • [27] Malignancy rates in patients with rheumatoid arthritis treated with tocilizumab
    Rubbert-Roth, Andrea
    Sebba, Anthony
    Brockwell, Laura
    Kelman, Ariella
    Porter-Brown, Benjamin
    Pulley, Jennifer
    Napalkov, Pavel
    van Vollenhoven, Ronald F.
    RMD OPEN, 2016, 2 (01):
  • [28] Malignancy in patients with rheumatoid arthritis treated with methotrexate - Reply
    Usman, AR
    Yunus, MB
    JOURNAL OF RHEUMATOLOGY, 1997, 24 (04) : 806 - 807
  • [29] Occurrence of Serious Infection in Patients with Rheumatoid Arthritis Treated with Biologics and Denosumab Observed in a Clinical Setting
    Lau, Arthur N.
    Wong-Pack, Matthew
    Rodjanapiches, Rod
    Ioannidis, George
    Wade, Sally
    Spangler, Leslie
    Balasubramanian, Akhila
    Pannacciulli, Nicola
    Lin, Celia J. F.
    Roy-Gayos, Patrick
    Bensen, William G.
    Bensen, Robert
    Adachi, Jonathan D.
    JOURNAL OF RHEUMATOLOGY, 2018, 45 (02) : 170 - 176
  • [30] Efficacy of Therapeutic Education for Patients With Rheumatoid Arthritis Treated With Biologics
    Bouden, Selma
    Ben Ayed, Hiba
    Khemir, Haifa
    Rouached, Leila
    Ben Tekaya, Aicha
    Mahmoud, Ines
    Tekaya, Raoudha
    Saidane, Olfa
    Abdelmoula, Leila
    MUSCULOSKELETAL CARE, 2025, 23 (01)
12345